A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score
Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-31
Target enrollment:
Participant gender:
Summary
Figure out the Efficacy and Safety of Azacitidine Combined with BUCY2 Conditioning Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome with Moderate High IPSS-M Score
Phase:
NA
Details
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology